glycyrrhizic acid has been researched along with Heart Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, Y; Shi, Y; Wang, X; Yang, B; Yang, J | 1 |
| Dong, RQ; Gao, HK; Hu, ZW; Li, M; Peng, D; Wu, RN; Wu, YQ; Yu, TY; Zhang, XW; Zhao, C; Zhou, JC | 1 |
| Bao, HY; Hu, ZW; Ma, YG; Sun, W; Yu, SS; Zhang, XW | 1 |
3 other study(ies) available for glycyrrhizic acid and Heart Diseases
| Article | Year |
|---|---|
Glycyrrhizic acid attenuates myocardial injury: Involvement of RIP140/NF-kB Pathway.
Topics: Adaptor Proteins, Signal Transducing; Animals; Biomarkers; Cytokines; Gene Expression Regulation; Glycyrrhizic Acid; Heart Diseases; Isoproterenol; L-Lactate Dehydrogenase; Male; Malondialdehyde; Molecular Structure; NF-kappa B; Nuclear Proteins; Nuclear Receptor Interacting Protein 1; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2017 |
Targeting HMGB1 ameliorates cardiac fibrosis through restoring TLR2-mediated autophagy suppression in myocardial fibroblasts.
Topics: Animals; Anti-Inflammatory Agents; Autophagy; Disease Models, Animal; Fibroblasts; Fibrosis; Glycyrrhizic Acid; Heart Diseases; HMGB1 Protein; Mice; Myocardium; Signal Transduction; Toll-Like Receptor 2 | 2018 |
[Blocking extracellular HMGB1 activity protects against doxorubicin induced cardiac injury in mice].
Topics: Animals; Anti-Inflammatory Agents; Collagen; Doxorubicin; Drug Interactions; Fibrosis; Glycyrrhizic Acid; Heart Diseases; HMGB1 Protein; Immunoprecipitation; Interleukin-17; Male; Mice; Mice, Inbred ICR; Myocardium; Random Allocation; Signal Transduction; Toll-Like Receptor 2; Transforming Growth Factor beta1; Up-Regulation | 2012 |